Last updated: June 2, 2026
Nystatin and Triamcinolone Acetonide Suppliers: Who Manufactures API, Drug Product, and Combination Products
Executive summary
Suppliers for nystatin and triamcinolone acetonide split into two supply chains: (1) API and intermediates for antifungal and corticosteroid actives, and (2) finished dosage forms (topical ointments, creams, suspensions) and combination products where a single SKU contains both agents. However, a complete, supplier-grade list (with specific companies, grades, and markets) cannot be produced from the information provided, and it would require a verified product/program mapping to specific NDCs, dosage forms, strengths, and jurisdictions.
If the goal is a procurement or licensing-ready answer, supplier identification must be tied to the exact marketed combination (or separate actives), because the supplier set differs materially by:
- dosage form (cream vs ointment vs topical suspension),
- strength (e.g., nystatin units per gram and triamcinolone concentration),
- marketed geography (US, EU, UK, MENA, etc.),
- whether procurement is for API or finished drug product.
What suppliers make nystatin (API and intermediates) for topical antifungals?
Answer: Nystatin API supply is typically handled by specialist API manufacturers and contract producers with fermentation-derived chemistry, with downstream availability for topical and oral antifungal products. Supplier sets vary by whether buyers need:
- nystatin USP/EP API,
- nystatin for compounded channels,
- nystatin as part of a finished topical product.
Which supplier types dominate the nystatin API supply chain?
- Fermentation and purification specialists (microbial/bioprocess origin).
- API re-packagers and distributors (brand-independent).
- CDMOs that formulate into topical dosage forms under customer ownership.
What documentation buyers usually require for nystatin API?
- CoA and analytical methods (HPLC assay, impurity profile).
- Compliance certifications (GMP status by site).
- Traceability for fermentation lots and purification steps.
- Stability data for target formulation.
What suppliers make triamcinolone acetonide (API) for topical corticosteroids?
Answer: Triamcinolone acetonide API supply concentrates among steroid API manufacturers and multi-product CDMOs with validated synthesis and crystallization controls. Availability depends on required specifications and whether the buyer needs:
- triamcinolone acetonide USP/EP API,
- micronized grades for topical performance,
- specific impurity limits aligned to US/EU monographs.
Common supplier categories for triamcinolone acetonide API
- Steroid-focused API manufacturers.
- Global CDMOs with dedicated hormonal steroid capabilities.
- Regional distributors sourcing from a limited set of primary producers.
What buyers usually validate for triamcinolone acetonide API?
- Particle size distribution if micronization is specified.
- Impurity profile and residual solvents.
- Polymorph/crystal form control where applicable.
- GMP documentation tied to the manufacturing site.
Who supplies finished drug products combining nystatin and triamcinolone acetonide?
Answer: Combination products are supplied by brand and generic manufacturers under specific NDCs/National authorizations, with formulation and stability differences that affect supplier eligibility. The supplier set depends on the exact marketed product.
Why combination-product suppliers differ from API suppliers
- The combination requires compatibility between antifungal and corticosteroid components.
- Formulation choices (base type, emulsifiers, viscosity, preservative system) drive different CDMO and filling capabilities.
- Regulatory dossiers are product-specific, so supplier switching is typically not interchangeable at the procurement level.
What procurement artifacts identify the correct supplier list?
- Market label strength and dosage form.
- NDC (US) or national authorization number (EU and other regions).
- Manufacturing site indicated on label or regulatory dossier.
Are there specific “combination” SKUs that determine supplier eligibility?
Answer: Yes. Supplier availability must be mapped to the exact SKU because nystatin-triamcinolone combination products exist in multiple dosage forms and strengths. Supplier identification is not reliable without SKU-level anchoring.
What to anchor in internal sourcing systems
- Strength (nystatin units per gram and triamcinolone acetonide percentage or mg/g).
- Dosage form (cream vs ointment vs topical solution/suspension).
- Packaging size (tube/jar/bottle) that drives filling line availability.
What suppliers matter most for US market procurement?
Answer: US procurement typically focuses on:
- Finished dose manufactures for the exact NDC combination, if buying drug product.
- API producers and CDMOs for contract manufacturing if producing under private label or for clinical supply.
What drives supplier shortlist size in the US?
- GMP inspection history for topical semi-solid products.
- Ability to supply at scale without specification drift.
- Regulatory dossier readiness (including ANDA/505(b)(2) alignment for product manufacturers).
What suppliers matter most for EU/UK market procurement?
Answer: EU/UK procurement shifts toward:
- MAH (marketing authorization holder) dossiers and named manufacturers on the certificate chain,
- licensed manufacturers under EU GMP,
- QP release sites and local batch release requirements.
What affects supplier selection in Europe?
- Pharmacopoeial specification alignment to EP monographs.
- Packaging language and batch labeling requirements by member state.
- Stability and shelf-life support for regional markets.
How strong is the supply risk for nystatin and triamcinolone acetonide?
Answer: Supply risk for these actives is usually manageable but can concentrate due to limited primary producers and specialized steroid processing. Risk increases when procurement requires:
- narrow impurity specs,
- steroid micronization or specific crystal forms,
- specific combination product stability targets.
Key risk drivers
- Single-site dependence for steroid API.
- Changes in microbial source and purification profiles for nystatin.
- CDMO slot availability for topical semi-solid manufacturing.
Key Takeaways
- Nystatin and triamcinolone acetonide supply splits into API supply and finished combination product supply.
- Supplier lists must be tied to the exact dosage form, strength, and market authorization/NDC to be procurement-reliable.
- Combination-product suppliers and API suppliers are rarely the same entity set.
- Supply risk is driven by specialization: microbial nystatin processing and steroid synthesis/crystal control for triamcinolone.
FAQs
- Which manufacturers supply nystatin as USP/EP API for topical creams and ointments?
- Who are the primary producers of triamcinolone acetonide API for pharmaceutical-grade topical products?
- Which companies make nystatin plus triamcinolone acetonide combination creams vs ointments?
- What CDMOs support topical semi-solid manufacturing for antifungal-steroid combinations?
- How do impurity specifications and particle size requirements affect sourcing for triamcinolone acetonide?
References
- Not provided in the prompt.
